Chip and Microfluidics Europe 2025" conference has been added to ResearchAndMarkets.com's offering. The Lab-on-a-Chip and Microfluidics Europe 2025 now in its 17th year brings together researchers and ...

Daniel Lubetzky invests in health and longevity companies through Camino Partners.

Made by combining several emerging technologies, human “bodyoids” could reduce animal testing, improve drug development, and alleviate organ shortages.

DeepSeek, which paved the way for China to establish its dominance in the global AI ecosystem, is being used in hospitals run ...

Beyond studying inflammation, Gutzeit is now applying her model to other areas. "A quarter of infertility cases are ...

Beneath the fantastical visuals and dry humor, at its core, Severance is about identity. It asks whether we are better or ...

Your cells constantly generate and conduct electricity that runs through your body to perform various functions. One such ...

The bill bars insurers from covering transplants done in China or organs sourced there.

The deal caps a turbulent three years for 2seventy bio. The company served as the oncology business of Bluebird Bio until Bluebird spun out 2seventy in 2021.

New brain-inspired hardware, architectures and algorithms could lead to more efficient, more capable forms of AI.

With RISC-V International, the body controlling the RISC-V instruction set, located in Switzerland for the past five years, RISC-V now has just as much right to call itself indigenous to Europe as ...

Although Huawei cannot legally obtain advanced chips made by TSMC, the company used shell companies last year to obtain compute chiplets for its Ascend 910 AI chips. The conspiracy was discovered ...